Betulinic acid induces apoptosis in skin cancer cells and differentiation in normal human keratinocytes

Experimental Dermatology

Volumn 14, Issue 10, 2005, Pages 736-743

  Galgon, Tino ^a   Wohlrab, Wolfgang ^a   Dräger, Birgit ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Apoptosis; Betulinic acid; Differentiation; Keratinocyte; Melanocyte

Indexed keywords

APOLIPOPROTEIN; BETULIC ACID; DNA FRAGMENT; FILAGGRIN; INVOLUCRIN; LIPOCORTIN 5;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL SURVIVAL; CELL TYPE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENCY; HUMAN; HUMAN CELL; KERATINOCYTE; MELANOCYTE; MELANOMA CELL; SKIN CANCER;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KERATINOCYTES; MELANOMA; NECROSIS; SKIN NEOPLASMS; TRITERPENES;

EID: 26444511113     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2005.00352.x     Document Type: Article

References (46)

1. Galgon T, Hoeke D, Draeger B. Identification and quantification of betulinic acid. Phytochem Analysis 1999: 10: 187-190.
2. Sheth K, Jolad S, Wiedhopf R, Cole J R. Tumor-inhibitory agent from Hyptis emoryi (Labiatae). J Pharm Sci 1972: 61: 1819.
3. Tomas-Barberan F A, Hostettmann K. A cytotoxic triterpenoid and flavonoids from Crossopteryx febrifuga. Planta Med 1988: 54: 266-267.
4. Yasukawa K, Takido M, Matsumoto T, Takeuchi M, Nakagawa S. Sterol and triterpene derivatives from plants inhibit the effects of a tumor promoter, and sitosterol and betulinic acid inhibit tumor formation in mouse skin two-stage carcinogenesis. Oncology 1991: 48: 72-76.
5. Pisha E, Chai H, Lee I S et al. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat Med 1995: 1: 1046-1051.
6. Peto J. Cancer epidemiology in the last century and the next decade. Nature 2001: 411: 390-395.
7. Cascinelli N, Heerlyn M, Schneeberger A et al. What is the most promising strategy for the treatment of metastasizing melanoma? Exp Dermatol 2000: 9: 439-451.
8. Soengas M S, Lowe S W. Apoptosis and melanoma chemoresistance. Oncogene 2003: 22: 3138-3151.
9. Fulda S, Friesen C, Los M et al. Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res 1997: 57: 4956-4964.
10. Fulda S, Scaffidi C, Susin S A et al. Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J Biol Chem 1998: 273: 33942-33948.
11. Fulda S, Jeremias I, Steiner H H, Pietsch T, Debatin K M. Betulinic acid: a new cytotoxic agent against malignant brain-tumor cells. Int J Cancer 1999: 82: 435-441.
12. Tan Y, Yu R, Pezzuto J M. Betulinic acid-induced programmed cell death in human melanoma cells involves mitogen-activated protein kinase activation. Clin Cancer Res 2003: 9: 2866-2875.
13. Seizer E, Thallinger C, Hoeller C et al. Betulinic acid-induced Mcl-1 expression in human melanoma - mode of action and functional significance. Mol Med 2002: 8: 877-884.
14. Ehrhardt H, Fulda S, Fuehrer M, Debatin K M, Jeremias I. Betulinic acid-induced apoptosis in leukemia cells. Leukemia 2004: 18: 1406-1412.
15. Mukherjee P K, Saha K, Das J, Pal M, Saha B P. Studies on the anti-inflammatory activity of rhizomes of Nelumbo nucifera. Planta Med 1997: 63: 367-369.
16. Bringmann G, Saeb W, Assi L A et al. Betulinic acid: isolation from Triphyophyllum peltatum and Ancistrocladus heyneanus, antimalarial activity, and crystal structure of the benzyl ester. Planta Med 1997: 63: 255-257.
17. Ziegler H L, Franzyk H, Sairafianpour M et al. Erythrocyte membrane modifying agents and the inhibition of Plasmodium falciparum growth structure-activity relationships for betulinic acid analogues. Bioorg Med Chem 2004: 12: 119-130.
18. De Clercq E. New developments in anti-HIV chemotherapy. Curr Med Chem 2001: 8:1543-1572.
19. Zhou J. Small-molecule inhibition of human immunodeficiency virus type 1 replication by specific targeting of the final step of virion maturation. J Virol 2004: 78: 922-929.
20. Sawada N, Kataoka K, Kondo K et al. Betulinic acid augments the inhibitory effects of vincristine on growth and lung metastasis of B16F1O melanoma cells in mice. Br J Cancer 2005: 90: 1672-1678.
21. Fulda S, Jeremias I, Debatin K-M. Cooperation of betulinic acid and TRAIL to induce apoptosis in tumor cells. Oncogene 2004: 23: 7611-7620.
22. Selzer E, Pimentel E, Wacheck V et al. Effects of betulinic acid alone and in combination with irradiation in human melanoma cells. J Invest Dermatol 2000: 114: 935-940.
23. Salti G I, Kichina J V, Das Gupta T K et al. Betulinic acid reduces ultraviolet-C-induced DNA breakage in congenital melanocytic naeval cells: evidence for a potential role as a chemopreventive agent. Melanoma Res 2001: 11: 99-104.
24. Boukamp P, Petrussevska R T, Breitkreutz D, Hornung J, Markham A, Fusenig N E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988: 106: 761-771.
25. Gavrilova-Ruch O, Schonherr K, Gessner G et al. Effects of imipramine on ion channels and proliferation of IGR1 melanoma cells. J Membr Biol 2002: 188: 137-149.
26. Grafe F, Wohlrab W, Neubert R, Brandsch M. Carrier-mediated transport of clonidine in human keratinocytes. Eur J Pharm Sci 2004: 21: 309-312.
27. Boersma A W M, Nooter K, Oostrum R G, Stoter G. Quantification of apoptotic cells with fluorescein isothiocyanate-labeled annexin V in Chinese hamster ovary cell cultures treated with cisplatin. Cytometry 1996: 24: 123-130.
28. Eijnde van den S, Luijsterburg A, Boshart L et al. In situ detection of apoptosis during embryogenesis with annexin V: from whole mount to ultrastructure. Cytometry 1997: 29: 313-320.
29. Gorman M, Samali A, McGowan A, Cotter T. Use of flow cytometric techniques in studying mechanism of apoptosis in leukemic cells. Cytometry 1997: 29: 97-105.
30. Boyce S, Ham R. Calcium regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum free serial culture. J Invest Dermatol 1983: 81: 33s-39s.
31. Koester S K, Bolton W E. Intracellular markers. J Immunol Methods 2000: 243: 99-106.
32. Gandarillas A, Goldsmith L A, Gschmeissner S, Leigh I M, Watt FM. Evidence that apoptosis and terminal differentiation of epidermal keratinocytes are distinct processes. Exp Dermatol 1999: 8: 71-79.
33. Bowen A R, Hanks A N, Allen S M, Alexander A, Diedrich M J, Grossman D. Apoptosis regulators and responses in human melanocytic and keratinocytic cells. J Invest Dermatol 2003: 120: 48-55.
34. Candi E, Schmidt R, Melino G. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 2005: 6: 328-340.
35. Eckert R L, Crish J F, Robinson N A. The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. Physiol Rev 1997: 77: 397-424.
36. Hennings H, Michael D, Cheng C, Steinert P, Holbrook K, Yuspa S H. Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell 1980: 19: 245-254.
37. Zuco V, Supino R, Righetti S C et al. Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells. Cancer Lett 2002: 175: 17-25.
38. Galgon T, Riemschneider S, Podhaisky H-P, Dräger B, Wohlrab W. In: Bonnekoh B, Gollnik H, eds. Clinico-Experimental Advances in Dermatological Diagnostics and Treatment. Melsungen: Bibiomed, 2003: 163-175.
39. Maruoka Y, Harada H, Harada H et al. Keratinocytes become terminally differentiated in a process involving programmed cell death. Biochem Biophys Res Commun 1997: 238: 886-890.
40. Allombert-Blaise C, Tamiji S, Mortier L et al. Terminal differentiation of human epidermal keratinocytes involves mitochondria- and caspase-dependent cell death pathway. Cell Death Differ 2003: 10: 850-852.
41. Hata K, Hon K, Takahashi S. Differentiation- and apoptosis-inducing activities by pentacyclic triterpenes on a mouse melanoma cell line. S Nat Prod 2002: 65: 645-648.
42. Poon K-H, Zhang J, Wang C, Tse A K-W, Wan C-K, Fong W-F. Betulinic acid enhances 1α,25-dihydroxyvitamin D3-induced differentiation in human HL-60 promyelocytic leukemia cells. Anticancer Drugs 2004: 15: 619-624.
43. Böni R, Schuster C, Nehrhoff B, Burg G. Epidemiol skin cancer. Neuro Endocrinol Lett 2002: 23: 48-56.
44. Coebergh J W, Neumann H A, Vrints L W, van der Heijden L, Meijer W J, Verhagen-Teulings M T. Trends in the incidence of non-melanoma skin cancer in the SE Netherlands 1975-1988: a registry-based study. Br J Dermatol 1991: 125: 353-359.
45. Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2005: 41: 4-7.
46. McKenzie R C, Sabin E. Aberrant signalling and transcription factor activation as an explanation for the defective growth control and differentiation of keratinocytes in psoriasis: a hypothesis. Exp Dermatol 2003: 12: 337-345.